Xinyu Cheng
Henan Medical Key Laboratory Of Precise Prevention And Treatment Of Esophageal Cancer
Anyang, China
Anyang, China
Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 11 publications
Immunotherapy-based adjuvant treatment after neoadjuvant immunochemotherapy in esophageal squamous cell carcinoma according to pathological response.
Journal: Frontiers in immunology
Published: February 02, 2026
Number of Examined Lymph Nodes in the Highest Quartile Enhances Staging and Prognosis for Patients with Esophageal Cancer Receiving Neoadjuvant Therapy.
Journal: Annals of surgical oncology
Published: March 12, 2025
Addendum: Neoadjuvant nimotuzumab plus chemoradiotherapy compared to neoadjuvant chemoradiotherapy and neoadjuvant chemotherapy for locally advanced esophageal squamous cell carcinoma.
Journal: Oncotarget
Published: December 06, 2022
Real-World Efficacy and Safety of Sintilimab-Based Regimens against Advanced Esophageal Cancer: A Single-Center Retrospective Observational Study.
Journal: BioMed research international
Published: June 06, 2022
Development and Validation of a Nomogram for Predicting Overall Survival to Concurrent Chemoradiotherapy in Patients with Locally Advanced Esophageal Squamous Cell Carcinoma.
Journal: BioMed research international
Published: May 05, 2022
Deep Learning for Automated Contouring of Gross Tumor Volumes in Esophageal Cancer.
Journal: Frontiers in oncology
Published: March 08, 2022
Preoperative Chemotherapy for Limited-stage Small Cell Carcinoma of the Esophagus.
Journal: The Annals of thoracic surgery
Published: March 23, 2021
Outcomes of concurrent chemoradiotherapy versus chemotherapy alone for esophageal squamous cell cancer patients presenting with oligometastases.
Journal: Journal of thoracic disease
Published: June 11, 2019
Neoadjuvant nimotuzumab plus chemoradiotherapy compared to neoadjuvant chemoradiotherapy and neoadjuvant chemotherapy for locally advanced esophageal squamous cell carcinoma.
Journal: Oncotarget
Published: August 14, 2017
With or without consolidation chemotherapy using cisplatin/5-FU after concurrent chemoradiotherapy in stage II-III squamous cell carcinoma of the esophagus: A propensity score-matched analysis.
Journal: Radiotherapy and oncology : journal of the European Society for Therapeutic Radiology and Oncology
Published: July 02, 2017
Showing 1-11 of 11
Last Updated: 09/26/2026